{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:38:58Z","timestamp":1792172338550,"version":"4.4.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41574-024-01004-9","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T08:02:52Z","timestamp":1718697772000},"page":"588-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-4296","authenticated-orcid":false,"given":"Cyril","family":"Debuysschere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-0803","authenticated-orcid":false,"given":"Magloire Pandoua","family":"Nekoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-9826","authenticated-orcid":false,"given":"Enagnon Kazali","family":"Alidjinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-2074","authenticated-orcid":false,"given":"Didier","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69\u201382 (2014).","journal-title":"Lancet"},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","volume":"46","author":"BO Roep","year":"2003","unstructured":"Roep, B. O. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46, 305\u2013321 (2003).","journal-title":"Diabetologia"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot, F. & Lernmark, \u00c5. Genetic risk factors for type 1 diabetes. Lancet 387, 2331\u20132339 (2016).","journal-title":"Lancet"},{"key":"1004_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1464-5491.2009.02743.x","volume":"26","author":"EV Moltchanova","year":"2009","unstructured":"Moltchanova, E. V., Schreier, N., Lammi, N. & Karvonen, M. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet. Med. 26, 673\u2013678 (2009).","journal-title":"Diabet. Med."},{"key":"1004_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/pedi.12227","volume":"16","author":"C Patterson","year":"2015","unstructured":"Patterson, C. et al. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989\u20132008: little short-term influence of sunshine hours or average temperature. Pediatr. Diabetes 16, 573\u2013580 (2015).","journal-title":"Pediatr. Diabetes"},{"key":"1004_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1651-2227.2011.02410.x","volume":"101","author":"U S\u00f6derstr\u00f6m","year":"2012","unstructured":"S\u00f6derstr\u00f6m, U., Aman, J. & Hjern, A. Being born in Sweden increases the risk for type 1 diabetes \u2014 a study of migration of children to Sweden as a natural experiment. Acta Paediatr. 101, 73\u201377 (2012).","journal-title":"Acta Paediatr."},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-016-8592-1","volume":"52","author":"Z Wang","year":"2017","unstructured":"Wang, Z., Xie, Z., Lu, Q., Chang, C. & Zhou, Z. Beyond genetics: what causes type 1 diabetes. Clin. Rev. Allerg. Immunol. 52, 273\u2013286 (2017).","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"1004_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/BF00274777","volume":"31","author":"P Olmos","year":"1988","unstructured":"Olmos, P. et al. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31, 747\u2013750 (1988).","journal-title":"Diabetologia"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11154-006-9024-y","volume":"7","author":"H Peng","year":"2007","unstructured":"Peng, H. & Hagopian, W. Environmental factors in the development of type 1 diabetes. Rev. Endocr. Metab. Disord. 7, 149\u2013162 (2007).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1004_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1753-4887.2012.00513.x","volume":"70","author":"E Patelarou","year":"2012","unstructured":"Patelarou, E. et al. Current evidence on the associations of breastfeeding, infant formula, and cow\u2019s milk introduction with type 1 diabetes mellitus: a systematic review. Nutr. Rev. 70, 509\u2013519 (2012).","journal-title":"Nutr. Rev."},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s00125-013-2929-6","volume":"56","author":"LC Stene","year":"2013","unstructured":"Stene, L. C. & Gale, E. A. M. The prenatal environment and type 1 diabetes. Diabetologia 56, 1888\u20131897 (2013).","journal-title":"Diabetologia"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/dmrr.695","volume":"23","author":"N van der Werf","year":"2007","unstructured":"van der Werf, N., Kroese, F. G. M., Rozing, J. & Hillebrands, J.-L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 23, 169\u2013183 (2007).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1004_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","volume":"18","author":"MP Nekoua","year":"2022","unstructured":"Nekoua, M. P., Alidjinou, E. K. & Hober, D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 18, 503\u2013516 (2022). This Review highlights evidence that persistent Coxsackievirus B infection triggers or accelerates islet autoimmunity and T1DM in susceptible individuals.","journal-title":"Nat. Rev. Endocrinol."},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1399-5448.2007.00280.x","volume":"8","author":"G Soltesz","year":"2007","unstructured":"Soltesz, G., Patterson, C. & Dahlquist, G.; EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence \u2014 what can we learn from epidemiology? Pediatr. Diabetes 8, 6\u201314 (2007).","journal-title":"Pediatr. Diabetes"},{"key":"1004_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrendo.2010.27","volume":"6","author":"D Hober","year":"2010","unstructured":"Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6, 279\u2013289 (2010). The interplay between enterovirus infection with \u03b2-cells, the immune system and host genes in the pathogenesis of T1DM is discussed.","journal-title":"Nat. Rev. Endocrinol."},{"key":"1004_CR16","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00125-017-4365-5","volume":"60","author":"M L\u00f6nnrot","year":"2017","unstructured":"L\u00f6nnrot, M. et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 60, 1931\u20131940 (2017). A prospective study of 8,676 newborn babies reporting that viral respiratory infections are associated with an increased risk of islet autoimmunity.","journal-title":"Diabetologia"},{"key":"1004_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/dmrr.1258","volume":"27","author":"T Rasmussen","year":"2011","unstructured":"Rasmussen, T., Wits\u00f8, E., Tapia, G., Stene, L. C. & R\u00f8nningen, K. S. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab. Res. Rev. 27, 834\u2013837 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1004_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2013.158","volume":"167","author":"A Beyerlein","year":"2013","unstructured":"Beyerlein, A., Wehweck, F., Ziegler, A.-G. & Pflueger, M. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatr. 167, 800\u2013807 (2013).","journal-title":"JAMA Pediatr."},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/pedi.12547","volume":"19","author":"N Mustonen","year":"2018","unstructured":"Mustonen, N. et al. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk. Pediatr. Diabetes 19, 293\u2013299 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurpub\/ckv059","volume":"25","author":"H-Y Lee","year":"2015","unstructured":"Lee, H.-Y., Lu, C.-L., Chen, H.-F., Su, H.-F. & Li, C.-Y. Perinatal and childhood risk factors for early-onset type 1 diabetes: a population-based case-control study in Taiwan. Eur. J. Public Health 25, 1024\u20131029 (2015).","journal-title":"Eur. J. Public Health"},{"key":"1004_CR21","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s00125-018-4662-7","volume":"61","author":"PLD Ruiz","year":"2018","unstructured":"Ruiz, P. L. D. et al. Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study. Diabetologia 61, 1996\u20132004 (2018).","journal-title":"Diabetologia"},{"key":"1004_CR22","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00125-022-05786-3","volume":"65","author":"O Kordonouri","year":"2022","unstructured":"Kordonouri, O. et al. Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort. Diabetologia 65, 2098\u20132107 (2022).","journal-title":"Diabetologia"},{"key":"1004_CR23","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.2016.2181","volume":"315","author":"A Beyerlein","year":"2016","unstructured":"Beyerlein, A., Donnachie, E., Jergens, S. & Ziegler, A.-G. Infections in early life and development of type 1 diabetes. JAMA 315, 1899\u20131901 (2016).","journal-title":"JAMA"},{"key":"1004_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2429","volume":"33","author":"R Wu","year":"2023","unstructured":"Wu, R. et al. Respiratory infections and type 1 diabetes: potential roles in pathogenesis. Rev. Med. Virol. 33, e2429 (2023).","journal-title":"Rev. Med. Virol."},{"key":"1004_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s42003-021-02594-0","volume":"4","author":"D Ho","year":"2021","unstructured":"Ho, D. et al. Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk. Commun. Biol. 4, 1072 (2021).","journal-title":"Commun. Biol."},{"key":"1004_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. The architecture of SARS-CoV-2 transcriptome. Cell 181, 914\u2013921 (2020).","journal-title":"Cell"},{"key":"1004_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","volume":"43","author":"Y-C Liu","year":"2020","unstructured":"Liu, Y.-C., Kuo, R.-L. & Shih, S.-R. COVID-19: the first documented coronavirus pandemic in history. Biomed. J. 43, 328\u2013333 (2020).","journal-title":"Biomed. J."},{"key":"1004_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41421-021-00249-2","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell Discov. 7, 17 (2021).","journal-title":"Cell Discov."},{"key":"1004_CR29","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.2337\/dc20-1551","volume":"43","author":"R Unsworth","year":"2020","unstructured":"Unsworth, R. et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 43, e170\u2013e171 (2020).","journal-title":"Diabetes Care"},{"key":"1004_CR30","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.2337\/dc21-0969","volume":"45","author":"C Kamrath","year":"2022","unstructured":"Kamrath, C. et al. Incidence of type 1 diabetes in children and adolescents during the COVID-19 pandemic in Germany: results from the DPV registry. Diabetes Care 45, 1762\u20131771 (2022).","journal-title":"Diabetes Care"},{"key":"1004_CR31","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/dom.15024","volume":"25","author":"R Gesuita","year":"2023","unstructured":"Gesuita, R. et al. Trends and cyclic variation in the incidence of childhood type 1 diabetes in two Italian regions over 33 years and during the COVID-19 pandemic. Diabetes Obes. Metab. 25, 1698\u20131703 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"1004_CR32","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.2337\/dc20-1321","volume":"43","author":"I Rabbone","year":"2020","unstructured":"Rabbone, I. et al. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care 43, 2870\u20132872 (2020).","journal-title":"Diabetes Care"},{"key":"1004_CR33","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1002\/jmv.27996","volume":"94","author":"M Rahmati","year":"2022","unstructured":"Rahmati, M. et al. The global impact of COVID\u201019 pandemic on the incidence of pediatric new\u2010onset type 1 diabetes and ketoacidosis: a systematic review and meta\u2010analysis. J. Med. Virol. 94, 5112\u20135127 (2022).","journal-title":"J. Med. Virol."},{"key":"1004_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D\u2019Souza","year":"2023","unstructured":"D\u2019Souza, D. et al. Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw. Open 6, e2321281 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1004_CR35","unstructured":"Ruiz, P. L. D. et al. SARS-CoV-2 infection and subsequent risk of type 1 diabetes in 1.2 million children [abstract 233]. EASD 2022. https:\/\/www.easd.org\/media-centre\/home.html#!resources\/sars-cov-2-infection-and-subsequent-risk-of-type-1-diabetes-in-1-2-million-children-3e68c8b2-dde1-43aa-8d75-af7356502994 (2022)."},{"key":"1004_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33014","volume":"5","author":"EK Kendall","year":"2022","unstructured":"Kendall, E. K., Olaker, V. R., Kaelber, D. C., Xu, R. & Davis, P. B. Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Netw. Open 5, e2233014 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1004_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266809","volume":"17","author":"F Qeadan","year":"2022","unstructured":"Qeadan, F. et al. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS One 17, e0266809 (2022).","journal-title":"PLoS One"},{"key":"1004_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2023.16348","volume":"330","author":"M Lugar","year":"2023","unstructured":"Lugar, M. et al. SARS-CoV-2 infection and development of islet autoimmunity in early childhood. JAMA 330, 1151\u20131160 (2023).","journal-title":"JAMA"},{"key":"1004_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/dc22-0385","volume":"46","author":"PM McKeigue","year":"2023","unstructured":"McKeigue, P. M. et al. Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Diabetes Care 46, 921\u2013928 (2023).","journal-title":"Diabetes Care"},{"key":"1004_CR40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2337\/dc22-2351","volume":"46","author":"R Noorzae","year":"2023","unstructured":"Noorzae, R., Junker, T. G., Hviid, A. P., Wohlfahrt, J. & Olsen, S. F. Risk of type 1 diabetes in children is not increased after SARS-CoV-2 infection: a nationwide prospective study in Denmark. Diabetes Care 46, 1261\u20131264 (2023).","journal-title":"Diabetes Care"},{"key":"1004_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1515\/jpem-2021-0289","volume":"34","author":"A Messaaoui","year":"2021","unstructured":"Messaaoui, A., Hajselova, L. & Tenoutasse, S. Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium. J. Pediatr. Endocrinol. Metab. 34, 1319\u20131322 (2021).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1004_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/dia.2020.0609","volume":"23","author":"X Jia","year":"2021","unstructured":"Jia, X. et al. Prevalence of SARS-CoV-2 antibodies in children and adults with type 1 diabetes. Diabetes Technol. Ther. 23, 517\u2013521 (2021).","journal-title":"Diabetes Technol. Ther."},{"key":"1004_CR43","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jama.2022.14092","volume":"328","author":"M Rewers","year":"2022","unstructured":"Rewers, M. et al. SARS-CoV-2 infections and presymptomatic type 1 diabetes autoimmunity in children and adolescents from Colorado, USA, and Bavaria, Germany. JAMA 328, 1252\u20131255 (2022).","journal-title":"JAMA"},{"key":"1004_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1056\/NEJMc2216477","volume":"389","author":"JP Krischer","year":"2023","unstructured":"Krischer, J. P. et al. SARS-CoV-2 \u2014 no increased islet autoimmunity or type 1 diabetes in teens. N. Engl. J. Med. 389, 474\u2013475 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1004_CR45","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.2337\/db21-0831","volume":"71","author":"M Pietropaolo","year":"2022","unstructured":"Pietropaolo, M., Hotez, P. & Giannoukakis, N. Incidence of an insulin-requiring hyperglycemic syndrome in SARS-CoV-2-infected young individuals: is it type 1 diabetes? Diabetes 71, 2656\u20132663 (2022).","journal-title":"Diabetes"},{"key":"1004_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28833","volume":"95","author":"M Rahmati","year":"2023","unstructured":"Rahmati, M. et al. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: a systematic review and meta-analysis of cohort studies. J. Med. Virol. 95, e28833 (2023).","journal-title":"J. Med. Virol."},{"key":"1004_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7660985","volume":"2023","author":"C Kamrath","year":"2023","unstructured":"Kamrath, C., Eckert, A. J., Holl, R. W. & Rosenbauer, J. Impact of the COVID-19 pandemic on children and adolescents with new-onset type 1 diabetes. Pediatr. Diabetes 2023, e7660985 (2023). This meta-analysis, including 40 studies carried out worldwide, reports an increased incidence of T1DM during the COVID-19 pandemic as well as an increased risk of T1DM following SARS-CoV-2 infection.","journal-title":"Pediatr. Diabetes"},{"key":"1004_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02656-y","volume":"20","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 20, 444 (2022).","journal-title":"BMC Med."},{"key":"1004_CR49","doi-asserted-by":"publisher","first-page":"155330","DOI":"10.1016\/j.metabol.2022.155330","volume":"137","author":"H Lai","year":"2022","unstructured":"Lai, H. et al. Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism 137, 155330 (2022).","journal-title":"Metabolism"},{"key":"1004_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMc2018688","volume":"383","author":"F Rubino","year":"2020","unstructured":"Rubino, F. et al. New-onset diabetes in covid-19. N. Engl. J. Med. 383, 789\u2013790 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1004_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00284-022-02807-7","volume":"79","author":"N Eslami","year":"2022","unstructured":"Eslami, N. et al. SARS-CoV-2: receptor and co-receptor tropism probability. Curr. Microbiol. 79, 133 (2022).","journal-title":"Curr. Microbiol."},{"key":"1004_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 12, 8 (2020).","journal-title":"Int. J. Oral. Sci."},{"key":"1004_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"1004_CR54","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","volume":"88","author":"A Heurich","year":"2014","unstructured":"Heurich, A. et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 88, 1293\u20131307 (2014).","journal-title":"J. Virol."},{"key":"1004_CR55","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.isci.2020.101160","volume":"23","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience 23, 101160 (2020).","journal-title":"iScience"},{"key":"1004_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 31, 126\u2013140 (2021).","journal-title":"Cell Res."},{"key":"1004_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal. Transduct. Target. Ther. 5, 283 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1004_CR58","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856\u2013860 (2020).","journal-title":"Science"},{"key":"1004_CR59","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/biomedicines10081995","volume":"10","author":"J Shin","year":"2022","unstructured":"Shin, J., Toyoda, S., Fukuhara, A. & Shimomura, I. GRP78, a novel host factor for SARS-CoV-2: the emerging roles in COVID-19 related to metabolic risk factors. Biomedicines 10, 1995 (2022).","journal-title":"Biomedicines"},{"key":"1004_CR60","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41586-021-03925-1","volume":"598","author":"FA Lempp","year":"2021","unstructured":"Lempp, F. A. et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature 598, 342\u2013347 (2021).","journal-title":"Nature"},{"key":"1004_CR61","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.sbi.2022.102439","volume":"76","author":"FL Kearns","year":"2022","unstructured":"Kearns, F. L. et al. Spike-heparan sulfate interactions in SARS-CoV-2 infection. Curr. Opin. Struct. Biol. 76, 102439 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1004_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113874119","volume":"119","author":"R Amraei","year":"2022","unstructured":"Amraei, R. et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc. Natl Acad. Sci. USA 119, e2113874119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1004_CR63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317026121","volume":"121","author":"Z Liao","year":"2024","unstructured":"Liao, Z. et al. Human transferrin receptor can mediate SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA 121, e2317026121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1004_CR64","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","volume":"2","author":"C Wei","year":"2020","unstructured":"Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391\u20131400 (2020).","journal-title":"Nat. Metab."},{"key":"1004_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41422-021-00603-9","volume":"32","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann, M. & P\u00f6hlmann, S. Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1. Cell Res. 32, 1\u20132 (2022).","journal-title":"Cell Res."},{"key":"1004_CR66","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"1004_CR67","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.coi.2005.05.009","volume":"17","author":"YL Lau","year":"2005","unstructured":"Lau, Y. L. & Peiris, J. M. Pathogenesis of severe acute respiratory syndrome. Curr. Opin. Immunol. 17, 404\u2013410 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"1004_CR68","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"1004_CR69","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms18030563","volume":"18","author":"H Roca-Ho","year":"2017","unstructured":"Roca-Ho, H., Riera, M., Palau, V., Pascual, J. & Soler, M. J. Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int. J. Mol. Sci. 18, 563 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1004_CR70","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209610","volume":"16","author":"F Hikmet","year":"2020","unstructured":"Hikmet, F. et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16, e9610 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"1004_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/ijerph18010284","volume":"18","author":"J Qi","year":"2021","unstructured":"Qi, J. et al. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. Int. J. Env. Res. Public Health 18, 284 (2021).","journal-title":"Int. J. Env. Res. Public Health"},{"key":"1004_CR72","doi-asserted-by":"publisher","first-page":"596898","DOI":"10.3389\/fendo.2020.596898","volume":"11","author":"D Fignani","year":"2020","unstructured":"Fignani, D. et al. SARS-CoV-2 receptor angiotensin i-converting enzyme type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature. Front. Endocrinol. 11, 596898 (2020).","journal-title":"Front. Endocrinol."},{"key":"1004_CR73","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151551","volume":"6","author":"MMF Qadir","year":"2023","unstructured":"Qadir, M. M. F. et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight 6, e151551 (2023). SARS-CoV-2 infection is associated with thrombofibrosis of the pancreas in non-human primates and humans and is also associated with new-onset diabetes mellitus.","journal-title":"JCI Insight"},{"key":"1004_CR74","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","volume":"32","author":"I Kusmartseva","year":"2020","unstructured":"Kusmartseva, I. et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 32, 1041\u20131051 (2020).","journal-title":"Cell Metab."},{"key":"1004_CR75","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/dbi18-0019","volume":"68","author":"AM Mawla","year":"2019","unstructured":"Mawla, A. M. & Huising, M. O. Navigating the depths and avoiding the shallows of pancreatic islet cell transcriptomes. Diabetes 68, 1380\u20131393 (2019).","journal-title":"Diabetes"},{"key":"1004_CR76","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"C-T Wu","year":"2021","unstructured":"Wu, C.-T. et al. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 33, 1565\u20131576 (2021).","journal-title":"Cell Metab."},{"key":"1004_CR77","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","volume":"18","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 18, 2128\u20132130 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1004_CR78","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","volume":"3","author":"JA M\u00fcller","year":"2021","unstructured":"M\u00fcller, J. A. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149\u2013165 (2021). SARS-CoV-2 can infect human pancreatic endocrine cells and impair \u03b2-cell function.","journal-title":"Nat. Metab."},{"key":"1004_CR79","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41592-021-01171-x","volume":"18","author":"PV Kharchenko","year":"2021","unstructured":"Kharchenko, P. V. The triumphs and limitations of computational methods for scRNA-seq. Nat. Methods 18, 723\u2013732 (2021).","journal-title":"Nat. Methods"},{"key":"1004_CR80","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s13287-020-01977-0","volume":"11","author":"II Aigha","year":"2020","unstructured":"Aigha, I. I. & Abdelalim, E. M. NKX6.1 transcription factor: a crucial regulator of pancreatic \u03b2 cell development, identity, and proliferation. Stem Cell Res. Ther. 11, 459 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"1004_CR81","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","volume":"33","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab. 33, 1577\u20131591 (2021). SARS-CoV-2 antigens are detected in \u03b2-cells from pancreas necropsies of patients with COVID-19, and SARS-CoV-2 infection induces eIF2 pathway-mediated human \u03b2-cell transdifferentiation ex vivo.","journal-title":"Cell Metab."},{"key":"1004_CR82","doi-asserted-by":"publisher","first-page":"110508","DOI":"10.1016\/j.celrep.2022.110508","volume":"38","author":"V van der Heide","year":"2022","unstructured":"van der Heide, V. et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 38, 110508 (2022).","journal-title":"Cell Rep."},{"key":"1004_CR83","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","volume":"19","author":"DL Eizirik","year":"2023","unstructured":"Eizirik, D. L., Szymczak, F. & Mallone, R. Why does the immune system destroy pancreatic \u03b2-cells but not \u03b1-cells in type 1 diabetes? Nat. Rev. Endocrinol. 19, 425\u2013434 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1004_CR84","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/db21-0926","volume":"71","author":"M Ben Nasr","year":"2022","unstructured":"Ben Nasr, M. et al. Indirect and direct effects of SARS-CoV-2 on human pancreatic islets. Diabetes 71, 1579\u20131590 (2022). Inflammatory cytokines that are upregulated during COVID-19 in serum samples from patients can induce islet apoptosis.","journal-title":"Diabetes"},{"key":"1004_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000179","volume":"4","author":"M Hodik","year":"2016","unstructured":"Hodik, M. et al. Enterovirus infection of human islets of Langerhans affects \u03b2-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structure. BMJ Open Diabetes Res. Care 4, e000179 (2016).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1004_CR86","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41536-020-00099-8","volume":"5","author":"Y Yao","year":"2020","unstructured":"Yao, Y. & Wang, C. Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine. NPJ Regen. Med. 5, 14 (2020).","journal-title":"NPJ Regen. Med."},{"key":"1004_CR87","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1530\/JOE-17-0516","volume":"236","author":"M Bensellam","year":"2018","unstructured":"Bensellam, M., Jonas, J.-C. & Laybutt, D. R. Mechanisms of \u03b2-cell dedifferentiation in diabetes: recent findings and future research directions. J. Endocrinol. 236, R109\u2013R143 (2018).","journal-title":"J. Endocrinol."},{"key":"1004_CR88","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic \u03b2 cell dedifferentiation as a mechanism of diabetic \u03b2 cell failure. Cell 150, 1223\u20131234 (2012).","journal-title":"Cell"},{"key":"1004_CR89","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrm3043","volume":"12","author":"C Jopling","year":"2011","unstructured":"Jopling, C., Boue, S. & Belmonte, J. C. I. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat. Rev. Mol. Cell Biol. 12, 79\u201389 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1004_CR90","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.2337\/db16-1516","volume":"66","author":"JM Spaeth","year":"2017","unstructured":"Spaeth, J. M. et al. Defining a novel role for the Pdx1 transcription factor in islet \u03b2-cell maturation and proliferation during weaning. Diabetes 66, 2830\u20132839 (2017).","journal-title":"Diabetes"},{"key":"1004_CR91","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1004_CR92","doi-asserted-by":"publisher","first-page":"11740","DOI":"10.3390\/ijms231911740","volume":"23","author":"D Jarczak","year":"2022","unstructured":"Jarczak, D. & Nierhaus, A. Cytokine storm \u2014 definition, causes, and implications. Int. J. Mol. Sci. 23, 11740 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1004_CR93","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/medicina58020144","volume":"58","author":"C Zanza","year":"2022","unstructured":"Zanza, C. et al. Cytokine storm in COVID-19: immunopathogenesis and therapy. Medicina 58, 144 (2022).","journal-title":"Medicina"},{"key":"1004_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imcb.12615","volume":"101","author":"R Anindya","year":"2023","unstructured":"Anindya, R., Rutter, G. A. & Meur, G. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection. Immunol. Cell Biol. 101, 191\u2013203 (2023).","journal-title":"Immunol. Cell Biol."},{"key":"1004_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3529","volume":"38","author":"L Montefusco","year":"2022","unstructured":"Montefusco, L., Bolla, A. M. & Fiorina, P. Should we expect a wave of type 1 diabetes following SARS\u2010CoV\u20102 pandemic? Diabetes Metab. Res. Rev. 38, e3529 (2022).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1004_CR96","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.diabet.2020.10.002","volume":"47","author":"T Sathish","year":"2021","unstructured":"Sathish, T., Tapp, R. J., Cooper, M. E. & Zimmet, P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 47, 101204 (2021).","journal-title":"Diabetes Metab."},{"key":"1004_CR97","doi-asserted-by":"publisher","first-page":"731974","DOI":"10.3389\/fendo.2021.731974","volume":"12","author":"S Shao","year":"2021","unstructured":"Shao, S., Yang, Q., Pan, R., Yu, X. & Chen, Y. Interaction of severe acute respiratory syndrome coronavirus 2 and diabetes. Front. Endocrinol. 12, 731974 (2021).","journal-title":"Front. Endocrinol."},{"key":"1004_CR98","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","volume":"67","author":"A Coomans de Brach\u00e8ne","year":"2024","unstructured":"Coomans de Brach\u00e8ne, A. et al. Interferons are key cytokines acting on pancreatic islets in type 1 diabetes. Diabetologia 67, 908\u2013927 (2024).","journal-title":"Diabetologia"},{"key":"1004_CR99","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-592374\/v1","author":"K Millette","year":"2021","unstructured":"Millette, K. et al. SARS-CoV2 infects pancreatic beta cells in vivo and induces cellular and subcellular disruptions that reflect beta cell dysfunction. Preprint at Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-592374\/v1 (2021). The effects of SARS-CoV-2 on \u03b2-cells are investigated in vivo using a rhesus macaque model.","journal-title":"Res. Sq."},{"key":"1004_CR100","first-page":"378","volume":"5","author":"KD Moudgil","year":"2009","unstructured":"Moudgil, K. D. & Sercarz, E. E. Crypticity of self antigenic determinants is the cornerstone of a theory of autoimmunity. Discov. Med. 5, 378\u2013382 (2009).","journal-title":"Discov. Med."},{"key":"1004_CR101","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrendo.2016.30","volume":"12","author":"A Op de Beeck","year":"2016","unstructured":"Op de Beeck, A. & Eizirik, D. L. Viral infections in type 1 diabetes mellitus \u2014 why the \u03b2 cells? Nat. Rev. Endocrinol. 12, 263\u2013273 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1004_CR102","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/v13061025","volume":"13","author":"BA Desimmie","year":"2021","unstructured":"Desimmie, B. A. et al. Insights into SARS-CoV-2 persistence and its relevance. Viruses 13, 1025 (2021).","journal-title":"Viruses"},{"key":"1004_CR103","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jinf.2020.06.073","volume":"81","author":"M Gousseff","year":"2020","unstructured":"Gousseff, M. et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J. Infect. 81, 816\u2013846 (2020).","journal-title":"J. Infect."},{"key":"1004_CR104","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1016\/S2666-5247(23)00115-5","volume":"4","author":"D Buonsenso","year":"2023","unstructured":"Buonsenso, D. et al. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe 4, e745\u2013e756 (2023).","journal-title":"Lancet Microbe"},{"key":"1004_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1004_CR106","doi-asserted-by":"publisher","first-page":"eabf8396","DOI":"10.1126\/scitranslmed.abf8396","volume":"13","author":"GD de Melo","year":"2021","unstructured":"de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 13, eabf8396 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1004_CR107","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmv.27292","volume":"94","author":"N Yazdanpanah","year":"2022","unstructured":"Yazdanpanah, N. & Rezaei, N. Autoimmune complications of COVID\u201019. J. Med. Virol. 94, 54\u201362 (2022). This review highlights the development of several autoimmune diseases following SARS-CoV-2 infection.","journal-title":"J. Med. Virol."},{"key":"1004_CR108","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"1004_CR109","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","volume":"3","author":"L Montefusco","year":"2021","unstructured":"Montefusco, L. et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2. Infect. Nat. Metab. 3, 774\u2013785 (2021).","journal-title":"Infect. Nat. Metab."},{"key":"1004_CR110","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld, M. et al. Covid-19 and autoimmunity. Autoimmun. Rev. 19, 102597 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1004_CR111","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki, M. & Colonna, M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15, 471\u2013485 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1004_CR112","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.dsx.2020.11.012","volume":"14","author":"SK Boddu","year":"2020","unstructured":"Boddu, S. K., Aurangabadkar, G. & Kuchay, M. S. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab. Syndr. 14, 2211\u20132217 (2020).","journal-title":"Diabetes Metab. Syndr."},{"key":"1004_CR113","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.jaut.2019.06.012","volume":"103","author":"Y Pacheco","year":"2019","unstructured":"Pacheco, Y. et al. Bystander activation and autoimmunity. J. Autoimmun. 103, 102301 (2019).","journal-title":"J. Autoimmun."},{"key":"1004_CR114","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","volume":"41","author":"K Rahimi","year":"2020","unstructured":"Rahimi, K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol. Sci. 41, 3149\u20133156 (2020).","journal-title":"Neurol. Sci."},{"key":"1004_CR115","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana, J. et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369, m2094 (2020).","journal-title":"BMJ"},{"key":"1004_CR116","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/bjh.17024","volume":"190","author":"M Mah\u00e9vas","year":"2020","unstructured":"Mah\u00e9vas, M. et al. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series. Br. J. Haematol. 190, e224\u2013e229 (2020).","journal-title":"Br. J. Haematol."},{"key":"1004_CR117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/thy.2020.0363","volume":"31","author":"M Chen","year":"2021","unstructured":"Chen, M., Zhou, W. & Xu, W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid 31, 8\u201311 (2021).","journal-title":"Thyroid"},{"key":"1004_CR118","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti, C. & Bayry, J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 16, 413\u2013414 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1004_CR119","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/2666145415666221004111511","volume":"23","author":"G Akku\u015f","year":"2023","unstructured":"Akku\u015f, G. Newly-onset autoimmune diabetes mellitus triggered by COVID 19 infection: a case-based review. Endocr. Metab. Immune Disord. Drug Targets 23, 887\u2013893 (2023).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"1004_CR120","doi-asserted-by":"publisher","first-page":"983206","DOI":"10.3389\/fendo.2022.983206","volume":"13","author":"R Mishra","year":"2022","unstructured":"Mishra, R., Elshimy, G., Kannan, L., Jacob, A. & Raj, R. Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies. Front. Endocrinol. 13, 983206 (2022).","journal-title":"Front. Endocrinol."},{"key":"1004_CR121","first-page":"532","volume":"17","author":"S Gen\u00e7","year":"2021","unstructured":"Gen\u00e7, S. et al. Could COVID-19 trigger type 1 diabetes? Presentation of covid-19 case presented with diabetic ketoacidosis. Acta Endocrinol. 17, 532\u2013536 (2021).","journal-title":"Acta Endocrinol."},{"key":"1004_CR122","volume":"13","author":"M Alfishawy","year":"2021","unstructured":"Alfishawy, M., Nassar, M., Mohamed, M., Fatthy, M. & Elmessiery, R. M. New-onset type 1 diabetes mellitus with diabetic ketoacidosis and pancreatitis in a patient with COVID-19. Sci. Afr. 13, e00915 (2021).","journal-title":"Sci. Afr."},{"key":"1004_CR123","doi-asserted-by":"publisher","first-page":"628810","DOI":"10.3389\/fped.2021.628810","volume":"9","author":"K Nielsen-Saines","year":"2021","unstructured":"Nielsen-Saines, K., Li, E., Olivera, A. M., Martin-Blais, R. & Bulut, Y. Case report: insulin-dependent diabetes mellitus and diabetic keto-acidosis in a child with COVID-19. Front. Pediatrics 9, 628810 (2021).","journal-title":"Front. Pediatrics"},{"key":"1004_CR124","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00592-020-01570-0","volume":"57","author":"L Marchand","year":"2020","unstructured":"Marchand, L., Pecquet, M. & Luyton, C. Type 1 diabetes onset triggered by COVID-19. Acta Diabetol. 57, 1265\u20131266 (2020).","journal-title":"Acta Diabetol."},{"key":"1004_CR125","doi-asserted-by":"publisher","first-page":"102754","DOI":"10.1016\/j.autrev.2021.102754","volume":"20","author":"Z Gao","year":"2021","unstructured":"Gao, Z., Zhang, H., Liu, C. & Dong, K. Autoantibodies in COVID-19: frequency and function. Autoimmun. Rev. 20, 102754 (2021).","journal-title":"Autoimmun. Rev."},{"key":"1004_CR126","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"1004_CR127","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/apm.12011","volume":"120","author":"KT Coppieters","year":"2012","unstructured":"Coppieters, K. T., Wiberg, A. & Von Herrath, M. G. Viral infections and molecular mimicry in type 1 diabetes. APMIS 120, 941\u2013949 (2012).","journal-title":"APMIS"},{"key":"1004_CR128","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese, G. & Fl\u00f6el, A. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress. Chaperones 25, 731\u2013735 (2020).","journal-title":"Cell Stress. Chaperones"},{"key":"1004_CR129","doi-asserted-by":"publisher","first-page":"612584","DOI":"10.3389\/fimmu.2020.612584","volume":"11","author":"ASM Moin","year":"2021","unstructured":"Moin, A. S. M., Nandakumar, M., Diane, A., Dehbi, M. & Butler, A. E. The role of heat shock proteins in type 1 diabetes. Front. Immunol. 11, 612584 (2021).","journal-title":"Front. Immunol."},{"key":"1004_CR130","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.it.2010.11.001","volume":"32","author":"FJ Quintana","year":"2011","unstructured":"Quintana, F. J. & Cohen, I. R. The HSP60 immune system network. Trends Immunol. 32, 89\u201395 (2011).","journal-title":"Trends Immunol."},{"key":"1004_CR131","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2337\/diab.42.6.908","volume":"42","author":"K Brudzynski","year":"1993","unstructured":"Brudzynski, K. Insulitis-caused redistribution of heat-shock protein HSP60 inside \u03b2-cells correlates with induction of HSP60 autoantibodies. Diabetes 42, 908\u2013913 (1993).","journal-title":"Diabetes"},{"key":"1004_CR132","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/dmrr.712","volume":"23","author":"I Raz","year":"2007","unstructured":"Raz, I. et al. Treatment of new-onset type 1 diabetes with peptide DiaPep277\u00ae is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial. Diabetes Metab. Res. Rev. 23, 292\u2013298 (2007).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1004_CR133","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/jcm9072038","volume":"9","author":"F Cappello","year":"2020","unstructured":"Cappello, F., Marino Gammazza, A., Dieli, F., Conway de Macario, E. & Macario, A. J. Does SARS-CoV-2 trigger stress-induced autoimmunity by molecular mimicry? A hypothesis. J. Clin. Med. 9, 2038 (2020).","journal-title":"J. Clin. Med."},{"key":"1004_CR134","doi-asserted-by":"publisher","first-page":"109183","DOI":"10.1016\/j.intimp.2022.109183","volume":"112","author":"M Vahabi","year":"2022","unstructured":"Vahabi, M., Ghazanfari, T. & Sepehrnia, S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int. Immunopharmacol. 112, 109183 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"1004_CR135","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/v15051045","volume":"15","author":"CA Devaux","year":"2023","unstructured":"Devaux, C. A. & Camoin-Jau, L. Molecular mimicry of the viral spike in the SARS-CoV-2 vaccine possibly triggers transient dysregulation of ACE2, leading to vascular and coagulation dysfunction similar to SARS-CoV-2 infection. Viruses 15, 1045 (2023).","journal-title":"Viruses"},{"key":"1004_CR136","doi-asserted-by":"publisher","first-page":"102738","DOI":"10.1016\/j.jaut.2021.102738","volume":"125","author":"A Patrizio","year":"2021","unstructured":"Patrizio, A., Ferrari, S. M., Antonelli, A. & Fallahi, P. A case of Graves\u2019 disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J. Autoimmun. 125, 102738 (2021).","journal-title":"J. Autoimmun."},{"key":"1004_CR137","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jdi.13757","volume":"13","author":"H Sasaki","year":"2022","unstructured":"Sasaki, H. et al. Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: a case report. J. Diabetes Investig. 13, 1105\u20131108 (2022).","journal-title":"J. Diabetes Investig."},{"key":"1004_CR138","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.diabet.2022.101324","volume":"48","author":"X Tang","year":"2022","unstructured":"Tang, X., He, B., Liu, Z., Zhou, Z. & Li, X. Fulminant type 1 diabetes after COVID-19 vaccination. Diabetes Metab. 48, 101324 (2022).","journal-title":"Diabetes Metab."},{"key":"1004_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004274","volume":"20","author":"X Xiong","year":"2023","unstructured":"Xiong, X. et al. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: a population-based cohort study. PLoS Med. 20, e1004274 (2023).","journal-title":"PLoS Med."},{"key":"1004_CR140","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2020.11.006","volume":"32","author":"KC Coate","year":"2020","unstructured":"Coate, K. C. et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells. Cell Metab. 32, 1028\u20131040 (2020).","journal-title":"Cell Metab."},{"key":"1004_CR141","doi-asserted-by":"publisher","first-page":"103363","DOI":"10.1016\/j.ebiom.2021.103363","volume":"67","author":"M Garcia-Montojo","year":"2021","unstructured":"Garcia-Montojo, M. & Nath, A. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19. eBioMedicine 67, 103363 (2021).","journal-title":"eBioMedicine"},{"key":"1004_CR142","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94387","volume":"2","author":"S Levet","year":"2017","unstructured":"Levet, S. et al. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. JCI Insight 2, e94387 (2017).","journal-title":"JCI Insight"},{"key":"1004_CR143","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11892-019-1256-9","volume":"19","author":"S Levet","year":"2019","unstructured":"Levet, S. et al. Human endogenous retroviruses and type 1 diabetes. Curr. Diab Rep. 19, 141 (2019).","journal-title":"Curr. Diab Rep."},{"key":"1004_CR144","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.ebiom.2021.103341","volume":"66","author":"E Balestrieri","year":"2021","unstructured":"Balestrieri, E. et al. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. eBioMedicine 66, 103341 (2021).","journal-title":"eBioMedicine"},{"key":"1004_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01260-9","volume":"10","author":"JR Temerozo","year":"2022","unstructured":"Temerozo, J. R. et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome 10, 65 (2022).","journal-title":"Microbiome"},{"key":"1004_CR146","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2204399","volume":"387","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Maternal vaccination and risk of hospitalization for covid-19 among infants. N. Engl. J. Med. 387, 109\u2013119 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1004_CR147","doi-asserted-by":"publisher","first-page":"910138","DOI":"10.3389\/fimmu.2022.910138","volume":"13","author":"A Laguila Alto\u00e9","year":"2022","unstructured":"Laguila Alto\u00e9, A. et al. Vaccine protection through placenta and breastfeeding: the unmet topic in COVID-19 pandemic. Front. Immunol. 13, 910138 (2022).","journal-title":"Front. Immunol."},{"key":"1004_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287103","volume":"18","author":"A-M Rick","year":"2023","unstructured":"Rick, A.-M. et al. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies. PLoS One 18, e0287103 (2023).","journal-title":"PLoS One"},{"key":"1004_CR149","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","volume":"10","author":"Y Xie","year":"2022","unstructured":"Xie, Y. & Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 10, 311\u2013321 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1004_CR150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","volume":"71","author":"CE Barrett","year":"2022","unstructured":"Barrett, C. E. et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years \u2014 United States, March 1, 2020\u2013June 28, 2021. MMWR Morb. Mortal. Wkly Rep. 71, 59\u201365 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1004_CR151","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8866","volume":"6","author":"Z Naveed","year":"2023","unstructured":"Naveed, Z. et al. Association of COVID-19 infection with incident diabetes. JAMA Netw. Open 6, e238866 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1004_CR152","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003052","volume":"11","author":"O Reges","year":"2023","unstructured":"Reges, O. et al. Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients. BMJ Open Diabetes Res. Care 11, e003052 (2023).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1004_CR153","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5501\/wjv.v10.i5.275","volume":"10","author":"DB Shrestha","year":"2021","unstructured":"Shrestha, D. B. et al. New-onset diabetes in COVID-19 and clinical outcomes: a systematic review and meta-analysis. World J. Virol. 10, 275\u2013287 (2021).","journal-title":"World J. Virol."},{"key":"1004_CR154","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/dom.14269","volume":"23","author":"T Sathish","year":"2021","unstructured":"Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J. & Zimmet, P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes. Metab. 23, 870\u2013874 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"1004_CR155","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.pcd.2022.05.009","volume":"16","author":"M Banerjee","year":"2022","unstructured":"Banerjee, M., Pal, R. & Dutta, S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim. Care Diabetes 16, 591\u2013593 (2022).","journal-title":"Prim. Care Diabetes"},{"key":"1004_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24185-7","volume":"12","author":"P Ssentongo","year":"2022","unstructured":"Ssentongo, P., Zhang, Y., Witmer, L., Chinchilli, V. M. & Ba, D. M. Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci. Rep. 12, 20191 (2022).","journal-title":"Sci. Rep."},{"key":"1004_CR157","doi-asserted-by":"publisher","first-page":"1170156","DOI":"10.3389\/fpubh.2023.1170156","volume":"11","author":"J Li","year":"2023","unstructured":"Li, J. et al. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front. Public Health 11, 1170156 (2023).","journal-title":"Front. Public Health"},{"key":"1004_CR158","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/archdischild-2020-321220","volume":"107","author":"H Salmi","year":"2022","unstructured":"Salmi, H. et al. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch. Dis. Child. 107, 180\u2013185 (2022).","journal-title":"Arch. Dis. Child."},{"key":"1004_CR159","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.23394","volume":"5","author":"R Shulman","year":"2022","unstructured":"Shulman, R., Cohen, E., Stukel, T. A., Diong, C. & Guttmann, A. Examination of trends in diabetes incidence among children during the COVID-19 pandemic in Ontario, Canada, from March 2020 to September 2021. JAMA Netw. Open 5, e2223394 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1004_CR160","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.2337\/dc20-1633","volume":"43","author":"SR Tittel","year":"2020","unstructured":"Tittel, S. R. et al. Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care 43, e172\u2013e173 (2020).","journal-title":"Diabetes Care"},{"key":"1004_CR161","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"TL Van Belle","year":"2011","unstructured":"Van Belle, T. L., Coppieters, K. T. & Von Herrath, M. G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 91, 79\u2013118 (2011).","journal-title":"Physiol. Rev."},{"key":"1004_CR162","doi-asserted-by":"publisher","first-page":"113429","DOI":"10.1016\/j.psychres.2020.113429","volume":"293","author":"S Singh","year":"2020","unstructured":"Singh, S. et al. Impact of COVID-19 and lockdown on mental health of children and adolescents: a narrative review with recommendations. Psychiatry Res. 293, 113429 (2020).","journal-title":"Psychiatry Res."},{"key":"1004_CR163","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/BF03346384","volume":"31","author":"K Karavanaki","year":"2008","unstructured":"Karavanaki, K. et al. Psychological stress as a factor potentially contributing to the pathogenesis of type 1 diabetes mellitus. J. Endocrinol. Invest. 31, 406\u2013415 (2008).","journal-title":"J. Endocrinol. Invest."},{"key":"1004_CR164","doi-asserted-by":"publisher","first-page":"101793","DOI":"10.1016\/j.beem.2023.101793","volume":"37","author":"D Hirani","year":"2023","unstructured":"Hirani, D., Salem, V., Khunti, K. & Misra, S. Newly detected diabetes during the COVID-19 pandemic: what have we learnt? Best Pract. Res. Clin. Endocrinol. Metab. 37, 101793 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1004_CR165","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.3390\/ijms24108885","volume":"24","author":"AA Boboc","year":"2023","unstructured":"Boboc, A. A. et al. SARS-CoV-2 positive serology and islet autoantibodies in newly diagnosed pediatric cases of type 1 diabetes mellitus: a single-center cohort study. Int. J. Mol. Sci. 24, 8885 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1004_CR166","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2337\/dc20-2791","volume":"44","author":"C Kamrath","year":"2021","unstructured":"Kamrath, C. et al. Frequency of autoantibody-negative type 1 diabetes in children, adolescents, and young adults during the first wave of the COVID-19 pandemic in Germany. Diabetes Care 44, 1540\u20131546 (2021).","journal-title":"Diabetes Care"},{"key":"1004_CR167","doi-asserted-by":"publisher","first-page":"1168927","DOI":"10.3389\/fendo.2023.1168927","volume":"14","author":"L Zhou","year":"2023","unstructured":"Zhou, L., Qu, H., Zhang, Q., Hu, J. & Shou, L. Case report: fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. Front. Endocrinol. 14, 1168927 (2023).","journal-title":"Front. Endocrinol."},{"key":"1004_CR168","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.2337\/dc23-0536","volume":"46","author":"Y Pan","year":"2023","unstructured":"Pan, Y., Zhong, X., Qiu, W., Zhao, F. & Yao, J. New-onset fulminant type 1 diabetes after SARS-CoV-2 infection. Diabetes Care 46, e140\u2013e142 (2023).","journal-title":"Diabetes Care"},{"key":"1004_CR169","doi-asserted-by":"publisher","first-page":"A690","DOI":"10.1210\/jendso\/bvab048.1406","volume":"5","author":"AH Martinez","year":"2021","unstructured":"Martinez, A. H., Hicks, K. A., Moorjani, T. P., Bell, J. & Lin, Y. A case of autoantibody negative pediatric diabetes mellitus with marked insulin resistance concomitant with COVID-19: a novel form of disease? J. Endocr. Soc. 5, A690\u2013A691 (2021).","journal-title":"J. Endocr. Soc."},{"key":"1004_CR170","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s42255-020-00281-8","volume":"2","author":"T Hollstein","year":"2020","unstructured":"Hollstein, T. et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat. Metab. 2, 1021\u20131024 (2020).","journal-title":"Nat. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01004-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T09:07:22Z","timestamp":1726132042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":170,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-01004-9","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"assertion":[{"value":"23 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}